Skip to main content
Open Access Publications from the University of California

Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30IIaccessory protein and the induction of oncogenic cellular transformation by p30II/c-MYC

  • Author(s): Romeo, MM
  • Ko, B
  • Kim, J
  • Brady, R
  • Heatley, HC
  • He, J
  • Harrod, CK
  • Barnett, B
  • Ratner, L
  • Lairmore, MD
  • Martinez, E
  • Lüscher, B
  • Robson, CN
  • Henriksson, M
  • Harrod, R
  • et al.

© 2014 Elsevier Inc. The human T-cell leukemia retrovirus type-1 (HTLV-1) p30IIprotein is a multifunctional latency-maintenance factor that negatively regulates viral gene expression and deregulates host signaling pathways involved in aberrant T-cell growth and proliferation. We have previously demonstrated that p30IIinteracts with the c-MYC oncoprotein and enhances c-MYC-dependent transcriptional and oncogenic functions. However, the molecular and biochemical events that mediate the cooperation between p30IIand c-MYC remain to be completely understood. Herein we demonstrate that p30IIinduces lysine-acetylation of the c-MYC oncoprotein. Acetylation-defective c-MYC Lys→Arg substitution mutants are impaired for oncogenic transformation with p30IIin c-myc-/-HO15.19 fibroblasts. Using dual-chromatin-immunoprecipitations (dual-ChIPs), we further demonstrate that p30IIis present in c-MYC-containing nucleoprotein complexes in HTLV-1-transformed HuT-102 T-lymphocytes. Moreover, p30IIinhibits apoptosis in proliferating cells expressing c-MYC under conditions of genotoxic stress. These findings suggest that c-MYC-acetylation is required for the cooperation between p30II/c-MYC which could promote proviral replication and contribute to HTLV-1-induced carcinogenesis.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View